MedPath

on-randomized control study of the evaluation for the switching entecavir to tenofovir alafenamide fumarate in patients with chronic HBV infectio

Not Applicable
Conditions
chronic HBV infection
Registration Number
JPRN-UMIN000032728
Lead Sponsor
Kitasato University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients whose CCr is lower than 15ml/min 2) Patients who are pregnant or have possibilities of pregnancy 3) Patients who are infected HIV or HCV 4) Patients who are considered to be inappropriate for this study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath